Showing results (351-360 of 867) with videos related to
Sort By:
Pageof 87
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2022
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia ASilvia Spena, Andrea Cairo, Emanuela Pappalardo, et al.Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defectsAnna Lecchi, Marco Capecchi, Lidia Padovan, et al.Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Erratum to 'A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays.' [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 3, March 2023, 100139]Paola Colpani, Luciano Baronciani, Francesca Stufano, et al.Chest|September 24, 2004
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJeffrey J Popma, Peter Berger, E Magnus Ohman, et al.Circulation|April 30, 2019
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery DiseasePaul A Gurbel, Keith A A Fox, Udaya S Tantry, et al.Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Strain history dependence of the nonlinear stress response of fibrin and collagen networksStefan Münster, Louise M Jawerth, Beverly A Leslie, et al.Blood|September 23, 2011
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivoJonathan W Yau, Alan R Stafford, Peng Liao, et al.Thrombosis and Haemostasis|December 2, 2006
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injuryRolf Dario Frank, Todd Holscher, Gernot Schabbauer, et al.Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitroZeyu Guan, Roxanna Wang, Rawaa H Hussain, et al.American Heart Journal|June 15, 2016
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tankJames A Reiffel, Jeffrey I Weitz, Paul Reilly, et al.Pageof 87